amiodarone has been researched along with meglumine antimoniate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Bolao, I; Segura, I | 1 |
| Anversa, L; Batista, LR; Cuba, MB; Dias da Silva, VJ; Martins, TY; Nogueira Nascentes, GA; Ramirez, LE; Richini Pereira, VB; Ruiz, LDS; Salles Tiburcio, MG | 1 |
| Bahrami, S; Bemani, E; Oryan, A | 1 |
3 other study(ies) available for amiodarone and meglumine antimoniate
| Article | Year |
|---|---|
Meglumine antimoniate, amiodarone and torsades de pointes: a case report.
Topics: Aged; Amiodarone; Antiprotozoal Agents; Electrocardiography; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission, Spontaneous; Torsades de Pointes | 1999 |
Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis.
Topics: Amiodarone; Animals; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hindlimb; Histocytochemistry; Itraconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin; Treatment Outcome | 2017 |
Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Topics: Adiponectin; Amiodarone; Animals; Anti-Arrhythmia Agents; Antiprotozoal Agents; Cell Line; Female; Glutathione Peroxidase; Inhibitory Concentration 50; Interleukin-6; Leishmania major; Leishmaniasis, Cutaneous; Lymph Nodes; Macrophages; Malondialdehyde; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Parasite Load; Random Allocation; Skin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |